Behavioural Pharmacology 2013-09-01

The relative reinforcing strength of methamphetamine and D-amphetamine in monkeys self-administering cocaine.

Joshua A Lile, Richard J Charnigo, Michael A Nader

Index: Behav. Pharmacol. 24(5-6) , 482-5, (2013)

Full Text: HTML

Abstract

Epidemiological data indicate that rates of methamphetamine misuse surpass those of D-amphetamine, but self-administration research in animals and humans has not typically demonstrated differences in their reinforcing effects. The present study used a within-session, exponentially increasing progressive-ratio schedule and extended-access conditions to assess the relative reinforcing strength of D-amphetamine and methamphetamine in rhesus monkeys (n=5) trained to self-administer cocaine. A range of doses of methamphetamine (0.003-0.1 mg/kg/injection), D-amphetamine (0.003-0.1 mg/kg/injection), and cocaine (0.003-0.3 mg/kg/injection) was tested to capture the ascending and descending limbs of the dose-effect functions. Each drug functioned as a reinforcer, but the peak number of self-administered D-amphetamine injections was significantly lower compared with methamphetamine and cocaine; the peak number of self-administered injections of cocaine and methamphetamine did not differ. Although differences in availability and other social factors likely impact relative rates of abuse, the present data suggest that the greater reinforcing strength of methamphetamine contributes to its increased use compared with D-amphetamine.


Related Compounds

Related Articles:

Dopamine receptors and the persistent neurovascular dysregulation induced by methamphetamine self-administration in rats.

2014-11-01

[J. Pharmacol. Exp. Ther. 351(2) , 432-9, (2014)]

Elevated urine zinc concentration reduces the detection of methamphetamine, cocaine, THC and opiates in urine by EMIT.

2013-01-01

[J. Anal. Toxicol. 37(9) , 665-9, (2013)]

Utilization of micellar electrokinetic chromatography-tandem mass spectrometry employed volatile micellar phase in the analysis of cathinone designer drugs.

2014-08-22

[J. Chromatogr. A. 1356 , 258-65, (2014)]

Combination of methamphetamine and HIV-1 gp120 causes distinct long-term alterations of behavior, gene expression, and injury in the central nervous system.

2015-01-01

[Exp. Neurol. 263 , 221-34, (2015)]

Stability of 3,4-methylenedioxymethampetamine (MDMA), 4-methylmethcathinone (mephedrone) and 3-trifluromethylphenylpiperazine (3-TFMPP) in formalin solution.

2013-09-01

[J. Anal. Toxicol. 37(7) , 440-6, (2013)]

More Articles...